RÉSUMÉ
OBJECTIVES: Montelukast is a well-known leukotriene receptor antagonist commonly used in treating allergic rhinitis and asthma. Omega-3 fatty acid is also known as an antiallergic and immunomodulator molecule. This study aimed to elucidate the efficacy of systemic montelukast and omega-3 fatty acid treatment in allergic rhinitis models in Wistar Hannover rats. METHODS: This research was conducted on 28 healthy Wistar Hannover rats weighing 250-350â¯g. After establishing the allergic rhinitis model, nasal symptoms were observed and scored, and the nasal mucosa of all rats was investigated histologically. Light microscopy was utilized to evaluate the degree of ciliary loss, goblet cell hyperplasia, vascular congestion, vascular proliferation, inflammatory cell infiltration, eosinophil infiltration, and hypertrophy in chondrocytes. RESULTS: As a result of the analysis of the data obtained from the study, it was determined that typical allergic rhinitis symptoms such as nasal scratching and sneezing were significantly reduced in the rats in the montelukast and omega-3 treated group, and these symptoms did not increase after repeated intranasal OVA-protease applications. Histological examinations after fish oil treatment did not reveal typical inflammatory changes in allergic rhinitis. None of the rats in the montelukast and omega-3 groups had any increase in goblet cells, whereas 14.3% of the rats in the control group and 28.6% of the rats in the allergic rhinitis group had mild increase. Last but not least, 71.4% of rats in the allergic rhinitis group had a moderate increase. The difference between the groups was statistically significant (pâ¯<â¯0.001). CONCLUSION: Regarding the outcomes of this research, it was observed that w-3 fatty acids had antiallergic effects, both histopathological and clinical, in the allergic rhinitis model. We believe that further randomized controlled trials incorporating larger cohorts are warranted to verify the use of omega-3 fatty acids in treating allergic rhinitis. The level of evidence of this article is Level 2.
Sujet(s)
Acétates , Cyclopropanes , Modèles animaux de maladie humaine , Acides gras omega-3 , Huiles de poisson , Antagonistes des leucotriènes , Ovalbumine , Quinoléines , Rat Wistar , Rhinite allergique , Sulfures , Animaux , Cyclopropanes/usage thérapeutique , Sulfures/usage thérapeutique , Acétates/usage thérapeutique , Quinoléines/usage thérapeutique , Acides gras omega-3/usage thérapeutique , Rhinite allergique/traitement médicamenteux , Rhinite allergique/anatomopathologie , Rats , Antagonistes des leucotriènes/usage thérapeutique , Huiles de poisson/usage thérapeutique , Mâle , Résultat thérapeutique , Muqueuse nasale/anatomopathologie , Muqueuse nasale/effets des médicaments et des substances chimiquesRÉSUMÉ
The aim of the present study was investigate the binding affinity of 5-((4-methoxyphenyl)thio)benzo[c][1,2,5]thiadiazole (MTDZ) with acetylcholinesterase (AChE). We also evaluated the effect of MTDZ against scopolamine (SCO)-induced amnesia in mice and we looked at the toxicological potential of this compound in mice. The binding affinity of MTDZ with AChE was investigated by molecular docking analyses. For an experimental model, male Swiss mice were treated daily with MTDZ (10 mg/kg, intragastrically (i.g.)) or canola oil (10 ml/kg, i.g.), and induced, 30 min later, with injection of SCO (0.4 mg/kg, intraperitoneally (i.p.)) or saline (0.9%, 5 ml/kg, i.p.) daily. From day 1 to day 10, mice were submitted to the behavioral tasks (Barnes maze, open-field, object recognition and location, Y-maze and step-down inhibitory avoidance tasks), 30 min after induction with SCO. On the tenth day, the animals were euthanized and blood was collected for the analysis of biochemical markers (creatinine, aspartate (AST), and alanine (ALT) aminotransferase). MTDZ interacts with residues of the AChE active site. SCO caused amnesia in mice by changing behavioral tasks. MTDZ treatment attenuated the behavioral changes caused by SCO. In ex vivo assay, MTDZ also protected against the alteration of AChE activity, reactive species (RS) levels, thiobarbituric acid reative species (TBARS) levels, catalase (CAT) activity in tissues, as well as in transaminase activities of plasma caused by SCO in mice. In conclusion, MTDZ presented anti-amnesic action through modulation of the cholinergic system and provided protection from kidney and liver damage caused by SCO.
Sujet(s)
Acetylcholinesterase/métabolisme , Amnésie/traitement médicamenteux , Anticholinestérasiques/usage thérapeutique , Nootropiques/usage thérapeutique , Sulfures/usage thérapeutique , Thiadiazoles/usage thérapeutique , Amnésie/induit chimiquement , Animaux , Apprentissage par évitement/effets des médicaments et des substances chimiques , Anticholinestérasiques/métabolisme , Mâle , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Souris , Simulation de docking moléculaire , Nootropiques/métabolisme , Liaison aux protéines , Scopolamine , Sulfures/métabolisme , Thiadiazoles/métabolismeRÉSUMÉ
OBJECTIVE: There is an urgent need for effective treatments to prevent or attenuate lung and systemic inflammation, endotheliitis, and thrombosis related to COVID-19. This study aimed to assess the effectiveness of a multidrug-therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid ("TNR4" therapy) to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico. DESIGN AND METHODS: A comparative effectiveness study was performed among 768 confirmed SARS-CoV-2 cases aged 18-80 years, who received ambulatory care at the Ministry of Health of Tlaxcala. A total of 481 cases received the TNR4 therapy, while 287 received another treatment (comparison group). All participants received home visits and/or phone calls for clinical evaluation during the 14 days after enrollment. RESULTS: Nearly 85% of cases who received the TNR4 recovered within 14 days compared to 59% in the comparison group. The likelihood of recovery within 14 days was 3.4 times greater among the TNR4 group than in the comparison group. Patients treated with TNR4 had a 75% and 81% lower risk of being hospitalized or death, respectively, than the comparison group. CONCLUSIONS: TNR4 therapy improved recovery and prevented the risk of hospitalization and death among ambulatory COVID-19 cases.
Sujet(s)
Acétates/usage thérapeutique , Antiviraux/usage thérapeutique , Acide acétylsalicylique/usage thérapeutique , Azithromycine/usage thérapeutique , Traitements médicamenteux de la COVID-19 , Cyclopropanes/usage thérapeutique , Ivermectine/usage thérapeutique , Quinoléines/usage thérapeutique , Sulfures/usage thérapeutique , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Association de médicaments , Hospitalisation , Humains , Mâle , Mexique , Adulte d'âge moyen , SARS-CoV-2 , Résultat thérapeutique , Jeune adulteRÉSUMÉ
The consumption of inadequately thermally treated fish is a public health risk due to the possible propagation of Anisakis larvae. The present study demonstrated the physiological and histopathological changes that accompanied an oral inoculation of crude extracts from fresh and thermally treated Anisakis Type II (L3) in rats. Worms were isolated from a marine fish and examined and identified using light and scanning electron microscopy. The study was performed in 6 rat groups: control (I), garlic oil (GO) inoculated (II), fresh L3 inoculated (III), thermally treated L3 inoculated (IV), fresh L3 + GO inoculated (V), and a thermally treated L3 + GO inoculated (VI) groups. Rats inoculated with fresh and thermally treated L3 showed abnormal liver and kidney functions associated with the destruction of normal architecture. GO produced a protective effect in rat groups inoculated with L3 extracts + GO via the amelioration of liver and kidney functions, which was confirmed by the marked normal structure on histology. Cooking of L3-infected fish induced severe alterations compared to uncooked fish. The administration of garlic before and after fish eating is recommended to avoid the dangerous effect of anisakids, even if they are cooked.
Sujet(s)
Composés allyliques , Anisakiase , Anisakis , Sulfures , Composés allyliques/pharmacologie , Composés allyliques/usage thérapeutique , Animaux , Anisakiase/traitement médicamenteux , Anisakiase/prévention et contrôle , Anisakis/effets des médicaments et des substances chimiques , Anthelminthiques/pharmacologie , Anthelminthiques/usage thérapeutique , Cuisine (activité) , Poissons/parasitologie , Parasitologie alimentaire , Larve , Rats , Rat Wistar , Sulfures/pharmacologie , Sulfures/usage thérapeutiqueRÉSUMÉ
Abstract The consumption of inadequately thermally treated fish is a public health risk due to the possible propagation of Anisakis larvae. The present study demonstrated the physiological and histopathological changes that accompanied an oral inoculation of crude extracts from fresh and thermally treated Anisakis Type II (L3) in rats. Worms were isolated from a marine fish and examined and identified using light and scanning electron microscopy. The study was performed in 6 rat groups: control (I), garlic oil (GO) inoculated (II), fresh L3 inoculated (III), thermally treated L3 inoculated (IV), fresh L3 + GO inoculated (V), and a thermally treated L3 + GO inoculated (VI) groups. Rats inoculated with fresh and thermally treated L3 showed abnormal liver and kidney functions associated with the destruction of normal architecture. GO produced a protective effect in rat groups inoculated with L3 extracts + GO via the amelioration of liver and kidney functions, which was confirmed by the marked normal structure on histology. Cooking of L3-infected fish induced severe alterations compared to uncooked fish. The administration of garlic before and after fish eating is recommended to avoid the dangerous effect of anisakids, even if they are cooked.
Resumo O consumo de peixe inadequadamente tratado termicamente representa um risco para a saúde pública, com a possibilidade da propagação de larvas de Anisakis. O presente estudo demonstrou as alterações fisiológicas e histopatológicas acompanhadas de inoculação oral de extractos brutos de Anisakis tipo II (L3) frescos e termicamente tratados em ratos. Os vermes foram isolados de um peixe marinho, examinados e identificados por microscopia de luz e eletrônica de varredura. O estudo foi conduzido em 6 grupos de ratos: controle (I), óleo de alho (GO) inoculado (II), L3 fresco inoculado (III), L3 tratado termicamente inoculado (IV), L3 fresco + GO inoculado (V), e um grupo L3 + GO tratado termicamente inoculado (VI). Observou-se que ratos inoculados com L3 fresco e tratados termicamente mostraram funções hepáticas e renais anormais, associadas à destruição da sua arquitetura normal. GO produziu um efeito protector em grupos de ratos inoculados com extractos L3 + GO através da melhoria das funções do fígado e dos rins, o que foi confirmado pela estrutura normal marcada da sua histologia. A cozedura de peixes infectados com L3 induziu alterações mais graves do que os peixes não cozidos. Recomenda-se a administração de alho antes e depois do consumo de peixe, para evitar o efeito perigoso dos anisakids, mesmo que sejam cozidos.
Sujet(s)
Animaux , Rats , Sulfures/pharmacologie , Anisakis/effets des médicaments et des substances chimiques , Anisakiase/prévention et contrôle , Anisakiase/traitement médicamenteux , Composés allyliques/usage thérapeutique , Composés allyliques/pharmacologie , Sulfures/usage thérapeutique , Parasitologie alimentaire , Rat Wistar , Cuisine (activité) , Poissons/parasitologie , Larve , Anthelminthiques/usage thérapeutique , Anthelminthiques/pharmacologieRÉSUMÉ
Many types of cancers have a well-established dependence on glutamine metabolism to support survival and growth, a process linked to glutaminase 1 (GLS) isoforms. Conversely, GLS2 variants often have tumor-suppressing activity. Triple-negative (TN) breast cancer (testing negative for estrogen, progesterone, and Her2 receptors) has elevated GLS protein levels and reportedly depends on exogenous glutamine and GLS activity for survival. Despite having high GLS levels, we verified that several breast cancer cells (including TN cells) express endogenous GLS2, defying its role as a bona fide tumor suppressor. Moreover, ectopic GLS2 expression rescued cell proliferation, TCA anaplerosis, redox balance, and mitochondrial function after GLS inhibition by the small molecule currently in clinical trials CB-839 or GLS knockdown of GLS-dependent cell lines. In several cell lines, GLS2 knockdown decreased cell proliferation and glutamine-linked metabolic phenotypes. Strikingly, long-term treatment of TN cells with another GLS-exclusive inhibitor bis-2'-(5-phenylacetamide-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) selected for a drug-resistant population with increased endogenous GLS2 and restored proliferative capacity. GLS2 was linked to enhanced in vitro cell migration and invasion, mesenchymal markers (through the ERK-ZEB1-vimentin axis under certain conditions) and in vivo lung metastasis. Of concern, GLS2 amplification or overexpression is linked to an overall, disease-free and distant metastasis-free worse survival prognosis in breast cancer. Altogether, these data establish an unforeseen role of GLS2 in sustaining tumor proliferation and underlying metastasis in breast cancer and provide an initial framework for exploring GLS2 as a novel therapeutic target.
Sujet(s)
Tumeurs du sein/anatomopathologie , Carcinogenèse/anatomopathologie , Glutaminase/métabolisme , Tumeurs du poumon/secondaire , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Benzèneacétamides/pharmacologie , Benzèneacétamides/usage thérapeutique , Région mammaire/anatomopathologie , Région mammaire/chirurgie , Tumeurs du sein/mortalité , Tumeurs du sein/thérapie , Lignée cellulaire tumorale , Survie sans rechute , Femelle , Techniques de knock-down de gènes , Glutaminase/antagonistes et inhibiteurs , Humains , Adulte d'âge moyen , Pronostic , Sulfures/pharmacologie , Sulfures/usage thérapeutique , Thiadiazoles/pharmacologie , Thiadiazoles/usage thérapeutiqueRÉSUMÉ
Hydrogen sulfide (H2S) is a vasorelaxant gas with therapeutic potential in several diseases. However, effects of H2S donors in hypertensive pregnancy complicated by feto-placental growth restriction are unclear. Therefore, we aimed to examine and compare the effects of fast-releasing H2S donor (sodium hydrosulfide-NaHS) and slow-releasing H2S donor (GYY4137) in hypertension-in-pregnancy. Pregnant rats were distributed into four groups: normal pregnancy (Norm-Preg), hypertensive pregnancy (HTN-Preg), hypertensive pregnancy + NaHS (HTN-Preg + NaHS), and hypertensive pregnancy + GYY4137 (HTN-Preg + GYY). Systolic blood pressure, plasma H2S levels, fetal and placental weights, number of viable fetuses, litter size, and endothelium-dependent vasodilation were examined. Also, oxidative stress was assessed in placenta. We found that GYY4137 attenuated hypertension on gestational days 16 and 18, while NaHS presented antihypertensive effect only on gestational day 18. GYY4137, but not NaHS, increased plasma H2S levels. Greater fetal and placental weights were found with GYY4137 than NaHS treatment. Also, HTN-Preg + NaHS presented further reductions in placental weights when compared to HTN-Preg group. Number of viable fetuses and litter size presented no significant changes. GYY4137 reduced placental oxidative stress caused by hypertension, while greater increases in oxidative stress were found in HTN-Preg + NaHS than HTN-Preg group. Hypertensive pregnancy caused impaired endothelium-dependent vasodilation, while GYY4137 and NaHS treatments blunted endothelial dysfunction. Endothelium-dependent vasodilation was completely blocked by the nitric oxide synthase inhibitor. We conclude that slow-releasing H2S donor GYY4137 is advantageous compared with fast-releasing H2S-donor NaHS to attenuate hypertension-in-pregnancy and to protect against feto-placental growth restriction and oxidative stress.
Sujet(s)
Antihypertenseurs/usage thérapeutique , Retard de croissance intra-utérin/traitement médicamenteux , Sulfure d'hydrogène , Hypertension artérielle/traitement médicamenteux , Morpholines/usage thérapeutique , Composés organothiophosphorés/usage thérapeutique , Sulfures/usage thérapeutique , Animaux , Antihypertenseurs/métabolisme , Antihypertenseurs/pharmacologie , Aorte thoracique/effets des médicaments et des substances chimiques , Aorte thoracique/physiologie , Femelle , Retard de croissance intra-utérin/métabolisme , Retard de croissance intra-utérin/physiopathologie , Foetus/effets des médicaments et des substances chimiques , Sulfure d'hydrogène/sang , Hypertension artérielle/sang , Hypertension artérielle/métabolisme , Hypertension artérielle/physiopathologie , Taille de la portée/effets des médicaments et des substances chimiques , Malonaldéhyde/métabolisme , Morpholines/pharmacologie , Composés organothiophosphorés/pharmacologie , Placenta/effets des médicaments et des substances chimiques , Grossesse , Rat Wistar , Sulfures/pharmacologieRÉSUMÉ
Dysregulation of hydrogen sulphide (H2 S) producing enzymes has been related to hypertensive pregnancy, and H2 S donor, sodium hydrosulphide (NaHS) exerts antihypertensive effects, modulates angiogenic factors production and acts as an antioxidant. Moreover, reduction in nitric oxide (NO) bioavailability is related to hypertensive pregnancy and H2 S may interact with NO, modulating its production. We aimed to investigate the NaHS effects in hypertension-in-pregnancy and also in feto-placental parameters. Female Wistar rats (200-250 g) were mated and desoxycorticosterone acetate injections followed by replacement of water by 0.9% saline solution were used to induce hypertensive pregnancy. Rats were divided into four groups: normal pregnant (Norm-Preg), pregnant + NaHS (Preg+NaHS), hypertensive pregnant (HTN-Preg) and HTN-Preg+NaHS. Systolic blood pressure was increased in HTN-Preg and this increase was blunted in HTN-Preg+NaHS. Fetal and placental weights were decreased in HTN-Preg animals, while fetal growth restriction was improved in HTN-Preg+NaHS. Placental weight was lower in HTN-Preg+NaHS than in HTN-Preg; however, placental efficiency was re-established in HTN-Preg+NaHS rats. We observed that a partial contribution of placental NO, but not changes in anti-angiogenic factors may mediate the increases in placental efficiency in HTN-Preg+NaHS. HTN-Preg presented thoracic aorta hyperreactivity to phenylephrine while NaHS treatment blunted this hyperreactivity, which seems not to be related to NO-mediated relaxation induced by acetylcholine. Therefore, changes in vascular responsiveness promoted by NaHS treatment may underlie the beneficial effects in systolic blood pressure and feto-placental parameters in our study.
Sujet(s)
Sulfure d'hydrogène/métabolisme , Hypertension artérielle gravidique/traitement médicamenteux , Monoxyde d'azote/métabolisme , Placenta/effets des médicaments et des substances chimiques , Sulfures/pharmacologie , Vasodilatation/effets des médicaments et des substances chimiques , Animaux , Antihypertenseurs/pharmacologie , Antihypertenseurs/usage thérapeutique , Aorte/effets des médicaments et des substances chimiques , Aorte/physiopathologie , Pression sanguine/effets des médicaments et des substances chimiques , Femelle , Poids du foetus/effets des médicaments et des substances chimiques , Hypertension artérielle gravidique/métabolisme , Hypertension artérielle gravidique/physiopathologie , Malonaldéhyde/métabolisme , Néovascularisation physiologique/effets des médicaments et des substances chimiques , Nitrates/métabolisme , Nitrites/métabolisme , Placenta/métabolisme , Grossesse , Rats , Rat Wistar , Sulfures/usage thérapeutiqueRÉSUMÉ
The present study investigated the possible effect of BMMS in protecting against memory impairment in an Alzheimer's disease model induced by scopolamine in mice. Another objective was to evaluate the involvement of oxidative stress and Na+/K+ ATPase activity in cerebral cortex and hippocampus of mice. Male Swiss mice were divided into four groups: groups I and III received canola oil (10 ml/kg, intragastrically (i.g.)), while groups II and IV received BMMS (10 mg/kg, i.g.). Thirty minutes after treatments, groups III and IV received scopolamine (1 mg/kg, intraperitoneal (i.p.)), while groups I and II received saline (5 ml/kg, i.p.). Behavioral tests were performed thirty minutes after scopolamine or saline injection. Cerebral cortex and hippocampus were removed to determine the thiobarbituric acid reactive species (TBARS) levels, non-protein thiols (NPSH) content, catalase (CAT) and Na+/K+ ATPase activities. The results showed that BMMS pretreatment protected against the reduction in alternation and latency time induced by scopolamine in the Y-maze test and step-down inhibitory avoidance, respectively. In the Barnes maze, the latency to find the escape box and the number of holes visited were attenuated by BMMS. Locomotor and exploratory activities were similar in all groups. BMMS pretreatment protected against the increase in the TBARS levels, NPSH content and CAT activity, as well as the inhibition on the Na+/K+ ATPase activity caused by scopolamine in the cerebral cortex. In the hippocampus, no significant difference was observed. In conclusion, the present study revealed that BMMS protected against the impairment of retrieval of short-term and long-term memories caused by scopolamine in mice. Moreover, antioxidant effect and protection on the Na+/K+ ATPase activity are involved in the effect of compound against memory impairment in AD model induced by scopolamine.
Sujet(s)
Antioxydants/pharmacologie , Troubles de la mémoire/traitement médicamenteux , Mémoire/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Sodium-Potassium-Exchanging ATPase/métabolisme , Sulfures/pharmacologie , Animaux , Antioxydants/usage thérapeutique , Catalase/métabolisme , Cortex cérébral/effets des médicaments et des substances chimiques , Cortex cérébral/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Mâle , Troubles de la mémoire/induit chimiquement , Troubles de la mémoire/métabolisme , Souris , Scopolamine , Sulfures/usage thérapeutique , Substances réactives à l'acide thiobarbiturique/métabolismeRÉSUMÉ
OBJECTIVE: Oral myiasis is a rare infection for which treatment protocol has not yet been established. This article presents 2 cases treated with a combination of topical application of sulfuric ether and surgery. The reasons for the use of surgical therapy, as well as the possible advantages and disadvantages of drug-based treatments, are discussed. CASE REPORT: Two cases of oral myiasis are described, the first being observed in a 9-year-old child with hypotonic cerebral palsy, and the second in a 52-year-old adult, alcohol-dependent, both showing infection in the gingival sulcus. Both cases were successfully treated in a process that involved topical application of sulfuric ether, mechanical removal of larvae, and surgical debridement. CONCLUSIONS: Oral myiasis can be treated effectively with surgery after topical application of sulfuric ether. The use of drugs may suggest a therapeutic alternative, but still requires further study and experience to be implemented, especially in individuals with neurological disorders.
Sujet(s)
Maladies de la gencive/parasitologie , Myiases/chirurgie , Administration par voie topique , Alcoolisme/complications , Animaux , Paralysie cérébrale/complications , Enfant , Débridement , Humains , Larve/effets des médicaments et des substances chimiques , Mâle , Adulte d'âge moyen , Myiases/traitement médicamenteux , Sulfures/administration et posologie , Sulfures/usage thérapeutiqueRÉSUMÉ
BACKGROUND: The treatment of atrophic scars is difficult and dermal filler materials provide a simple alternative with immediate results. Esthélis® is an injectable non-animal crosslinked hyaluronic acid of Swiss origin characterized by a polydense cohesive matrix (CPM®) which produces a gel of uniform consistency with better biointegration to the tissues and a longer duration. OBJECTIVE: To evaluate Esthélis in the treatment of atrophic scars. PATIENTS AND METHODS: Twelve patients aged 18-56 years with facial atrophic scars caused by acne vulgaris, dog bite, piercing, basal cell carcinoma and leishmaniasis were treated with Esthélis. The injection technique was linear threading, serial puncture or a combination of both. Clinical efficacy was assessed independently by the authors and by patients immediately, one week and one month after the injection. Adverse events were registered. RESULTS: Authors described the results as moderate (27%), good (57%) and excellent (17%), immediately, one week and one month after the injection. Patients evaluated the cosmetic improvement as good (42%) or excellent (58%) one month after the treatment. Pain during the injection was described as slight or moderate. Only mild erythema was observed immediately after injection, which spontaneously resolved within few hours. CONCLUSION: Esthélis showed good or excellent results in most patients with atrophic scars, and these were perceived as even better when patients evaluated the cosmetic improvement. The best results were observed in patients with more deforming scars such as surgical scars or trauma.
Sujet(s)
Carcinome basocellulaire/traitement médicamenteux , Chlorobenzènes/usage thérapeutique , Cicatrice/traitement médicamenteux , Systèmes de délivrance de médicaments , Face , Acide hyaluronique/usage thérapeutique , Sulfures/usage thérapeutique , Acné juvénile/complications , Acné juvénile/anatomopathologie , Adulte , Atrophie , Carcinome basocellulaire/complications , Carcinome basocellulaire/anatomopathologie , Chlorobenzènes/effets indésirables , Cicatrice/anatomopathologie , Cicatrice/chirurgie , Techniques cosmétiques/effets indésirables , Excipients , Humains , Acide hyaluronique/effets indésirables , Injections , Adulte d'âge moyen , Ponctions , Sulfures/effets indésirables , Facteurs temps , Résultat thérapeutique , Jeune adulteRÉSUMÉ
The data compiled in the present review on dibenzyl trisulphide (DTS) isolated from Petiveria alliacea L (the guinea hen weed or anamu) revealed that the compound and its derivatives could be of tremendous pharmaceutical interest. The mode of action elucidated for DTS revealed that it is a mitogen activated protein extracellular regulated kinases 1 and 2 (MAPKinases erk1 and erk 2) signal transduction molecule. Dibenzyl trisulphide caused hyper-phosphorylation of growth factor induced MAPKinases (erk 1 and erk 2) phosphorylation, a process critical for the improvement of long term memory, and is implicated in neuronal growth. Dibenzyl trisulphide and its derivatives exhibited potent anti-proliferation/cytotoxic activity on a wide range of cancer cell lines. The cytotoxic activity of DTS was increased by 70-1000 fold when bound to albumin in vitro. Dibenzyl trisulphide seems to have a cytokine switching mechanism in which it down regulates cytokines from the Type I helper cells (Th -1 cell) pathway which contained several pro-inflammatory cytokines and up-regulates those on the Type 2 helper cells (Th-2) pathway. The trisulphide up-regulates some reticuloendothelial system parameters eg granulocyte counts and increased thymic and Peyer's patches masses via cell proliferation processes which are known to be regulated via the MAPKinase signal transduction pathway. When the zygotes ofAsternia pectinifera (Starfish) were exposed to DTS at concentration of 10 mM, a dose lethal to all cancer cells tested, it was observed that the sensitive process of protein biosynthesis was not affected Similarly, the proliferation of the HOFA human fibroblast, a noncancerous cell line, was not severely affected by DTS at 8.9 microM over seven days, a concentration also lethal to most cancer cell lines tested The implications of the findings will be highlighted in the present review.
Sujet(s)
Composés benzyliques/usage thérapeutique , Phytothérapie , Extraits de plantes , Sulfures/usage thérapeutique , Antigènes CD/physiologie , Composés benzyliques/pharmacologie , Cadhérines/physiologie , Humains , Transduction du signal/effets des médicaments et des substances chimiques , Sulfures/pharmacologie , Régulation positive/physiologieRÉSUMÉ
The data compiled in the present review on dibenzyl trisulphide (DTS) isolated from Petiveria alliacea L (the guinea hen weed or anamu) revealed that the compound and its derivatives could be of tremendous pharmaceutical interest. The mode of action elucidated for DTS revealed that it is a mitogen activated protein extracellular regulated kinases 1 and 2 (MAPKinases erk1 and erk 2) signal transduction molecule. Dibenzyl trisulphide caused hyper-phosphorylation of growth factor induced MAPKinases (erk 1 and erk 2) phosphorylation, a process critical for the improvement of long term memory, and is implicated in neuronal growth. Dibenzyl trisulphide and its derivatives exhibited potent anti-proliferation/cytotoxic activity on a wide range of cancer cell lines. The cytotoxic activity of DTS was increased by 70-1000 fold when bound to albumin in vitro. Dibenzyl trisulphide seems to have a cytokine switching mechanism in which it down regulates cytokines from the Type I helper cells (Th -1 cell) pathway which contained several pro-inflammatory cytokines and up-regulates those on the Type 2 helper cells (Th-2) pathway. The trisulphide up-regulates some reticuloendothelial system parameters eg granulocyte counts and increased thymic and Peyer's patches masses via cell proliferation processes which are known to be regulated via the MAPKinase signal transduction pathway. When the zygotes ofAsternia pectinifera (Starfish) were exposed to DTS at concentration of 10 mM, a dose lethal to all cancer cells tested, it was observed that the sensitive process of protein biosynthesis was not affected Similarly, the proliferation of the HOFA human fibroblast, a noncancerous cell line, was not severely affected by DTS at 8.9 microM over seven days, a concentration also lethal to most cancer cell lines tested The implications of the findings will be highlighted in the present review.
Los datos compilados en el presente estudio sobre el trisulfuro de dibencilo (TSD) aislado a partir de Petiveria alliacea L (yerba de Guinea, ó anamú) revelaron que el compuesto y sus derivados podrían tener extraordinario interés farmacéutico. El modo de acción esclarecido en el TSD, reveló que se trata de una molécula de transducción de señales de proteínas kinasas 1 y 2 (MAP quinasas ERk 1 y 2) reguladas extracelularmente y activadas por mitógenos. El trisulfuro de dibencilo causó hiperfosforilación de la fosforilación de las quinasas MAP (Erk 1 y 2) inducidas mediante factor de crecimiento, un proceso crítico para el mejoramiento de la memoria a largo plazo, y que está implicado en el crecimiento neuronal. El trisulfuro de dibencilo y sus derivados mostraron una poderosa actividad citotóxica y antiproliferativa en una amplia gama de líneas celulares de cáncer. La actividad citotóxica del TSD se incrementaba de 70 á 1000 veces, cuando se vinculaba a la albúmin in vitro. El trisulfuro de dibencilo parece poseer un mecanismo conmutador citoquínico que regula por decremento las citoquinas provenientes de la vía de las células auxiliares de tipo 1 (células Th-1), que contiene varias citoquinas pro-inflamatorias y regula por incremento las de la vía de las células auxiliares de tipo 2 (Th-2). El trisulfuro regula por incremento los parámetros del sistema reticuloendotelial, p.ej. los conteos de granulocitos y el aumento tanto de las masas tímicas como de las masas de placas de Peyer, a través de los procesos de proliferación celular, de los cuales se sabe que son regulados mediante la vía de la transducción de señales de la quinasa MAP. Cuando los cigotos de Asternia pectinifera (estrella de mar) fueron expuestos al TSD a una concentración de 10 mM una dosis letal para todas las células cancerosas sometidas a prueba se observó que el proceso sensible de biosíntesis de la proteína no era afectado. De modo similar, la proliferación del fibroblasto humano HOFA una línea celular no cancerosa no fue afectada severamente por el TSD a 8.9 µM en siete días una concentración letal para la mayoría de las líneas celulares cancerosas sometidas a prueba. Las implicaciones de los hallazgos se pondrán de relieve en el presente estudio
Sujet(s)
Humains , Composés benzyliques/usage thérapeutique , Extraits de plantes , Phytothérapie , Sulfures/usage thérapeutique , Antigènes CD/physiologie , Cadhérines/physiologie , Composés benzyliques/pharmacologie , Régulation positive/physiologie , Sulfures/pharmacologie , Transduction du signal/effets des médicaments et des substances chimiquesRÉSUMÉ
Effective medications to treat acne sometimes become unavailable in certain countries, either for economic reasons or for shortage of them in the pharmaceutical market. The purpose of this report is to review a series of drugs of topical and systemic use; some old and some new. The topical group includes agents such as sulfur, salicylic acid and the alpha-hydroxy acids, while the systemic group includes diaminodiphenylsulfone, clofazimine, ibuprofen and others. Some presumably useful physical methodologies and the recent findings in phototherapy, particularly the properties of blue light and blue-red light, are also reviewed. Finally, we report on the results obtained from the combined use of isotretinoin and methylprednisone in severe inflammatory acne, to prevent a possible triggering of the 'pseudo' acne fulminans.
Sujet(s)
Acné juvénile/thérapie , Anti-infectieux/usage thérapeutique , Composés du calcium/usage thérapeutique , Dapsone/usage thérapeutique , Glucocorticoïdes/usage thérapeutique , Photothérapie , Prednisone/usage thérapeutique , Sulfures/usage thérapeutique , Thiosulfates/usage thérapeutique , Composés du calcium/administration et posologie , Cryothérapie , Électrocoagulation , Humains , Peroxyde d'hydrogène/usage thérapeutique , Sulfures/administration et posologie , Thiosulfates/administration et posologieRÉSUMÉ
Eluciones susivas con distintos solventes del carbón activado, usado como adsorbente del Agua del Volcán Copahue (AVC) permitieron confirmar de nuevo que la extrema acidez de las muestras naturales obtenidas de la vertiente, no es la principal causa del efecto antibiótico, en contacto de breve período en las valoraciones biológicas. Los ensayos cromatográficos, aplicando reactivos microquímicos específicos y modificados, permitieron la detección de los principales compuestos acídicos, a partir de los eluidos residuales sucesivos, respectivamente obtenidos con acetato de etilo y con éter sulfúrico. Con acetato de metanólicos. Se sugiere que el AVC contiene, además de los productos sulfurosos bioactivos, otros elementos que actuarían en forma aditiva o sinérgica en los efectos biocidas y regenerativos, importantes en la crenoterapia
Sujet(s)
Carbone Activé (Santé Environnementale) , Antibiose , Argentine , Maladies de la peau/thérapie , Sulfures/usage thérapeutique , Algorithmes , Vert de bromocrésol , Bleu de bromophénol , Charbon de bois , Phénomènes chimiques , Chromatographie sur papier , Synergie des médicaments , Santé environnementaleRÉSUMÉ
Eluciones susivas con distintos solventes del carbón activado, usado como adsorbente del Agua del Volcán Copahue (AVC) permitieron confirmar de nuevo que la extrema acidez de las muestras naturales obtenidas de la vertiente, no es la principal causa del efecto antibiótico, en contacto de breve período en las valoraciones biológicas. Los ensayos cromatográficos, aplicando reactivos microquímicos específicos y modificados, permitieron la detección de los principales compuestos acídicos, a partir de los eluidos residuales sucesivos, respectivamente obtenidos con acetato de etilo y con éter sulfúrico. Con acetato de metanólicos. Se sugiere que el AVC contiene, además de los productos sulfurosos bioactivos, otros elementos que actuarían en forma aditiva o sinérgica en los efectos biocidas y regenerativos, importantes en la crenoterapia (AU)